DHL Express to suspend operations countrywide amid strike, lockout
An airplane stands in the hangar during the official launching ceremony of the Airbus A330-200 cargo airplane by the European Air Transport Leipzig GmbH (EAT) at the European DHL Express air freight hub in Schkeuditz near Leipzig, Germany, Friday, Oct. 12, 2018. (AP Photo/Jens Meyer)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
a day ago
- Globe and Mail
Peptide Synthesis Market to Hit USD 1.41 Billion by 2029 with 11.7% CAGR
"Thermo Fisher Scientific Inc. is one of the dominant players in the peptide synthesis market. The company's leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of various growth strategies." The market for peptide synthesis market is competitive, with key players strategizing to capture the majority market share. Prominent players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Kaneka Corporation (Japan), GenScript (China) The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in 2024 and an impressive US$ 1.41 Billion by 2029. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders. Advancements in solid-phase peptide synthesis (SPPS) and hybrid approaches have significantly improved efficiency, yield, and cost-effectiveness, fueling adoption in pharmaceutical R&D. The rise of personalized medicine has further expanded the need for custom peptide synthesis, supporting applications in targeted therapies and biomarker research. Emerging trends such as the integration of automation and AI-driven platforms among the instruments is further likely to fuel the market growth in coming years. Browse in-depth TOC on " Peptide Synthesis Market" 513 - Tables 55 - Figures 460 - Pages Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis market. The consumables segment is further bifurcated into reagents and other consumables. The reagents market is further divided into resins, amino acids, coupling reagents, dyes & fluorescent labeling reagents, deprotection agents, cleavage reagents, and other reagents. In 2023, the resins segment accounted for the largest share of the peptide synthesis market. Resins play an important role in solid-phase peptide synthesis (SPPS), the most widely used method for peptide production. For instance, polystyrene-based and PEG-based resins are extensively used due to their high stability and scalability. The instruments segment is further divided into peptide synthesizers, chromatography equipment, lyophilizers, and others. The peptide synthesizer segment is further divided into automated and manual peptide synthesizers. Peptide synthesizers dominated the instruments market due to their ability to automate and streamline peptide production, making them essential for research and industrial applications. The growing demand for custom peptides in drug discovery, diagnostic research, and therapeutic applications has further boosted the adoption of advanced synthesizers. The services segment is further divided into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. The peptide synthesis segment dominated the services segment. The increasing adoption of peptides in emerging fields such as personalized medicine, vaccine development, and epigenetics drives demand for custom synthesis solutions, fostering growth in the segment. Based on technique, the peptide synthesis market is segmented into chemical and biological. The chemical segment is further divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and others. The biological segment is divided into recombinant DNA technology and enzymes. The chemical segment dominated the market in 2023. The solid-phase peptide synthesis (SPPS) segment dominates the peptide synthesis market due to its efficiency, scalability, and widespread adoption in research and commercial applications. The dominance of SPPS is further driven by advancements in automation and reagent technologies, which have significantly reduced synthesis time and enhanced yield. Based on application, the market is divided into therapeutics, diagnostics, and research & development. Therapeutics by indication is further divided into cancer, diabetes, obesity, autoimmune disease, and other disease indications. Therapeutics by molecules is further segmented into peptide-based vaccines, peptide-drug conjugates (PDCs), peptide inhibitors, and other molecules. Therapeutic applications dominated the peptide synthesis market due to the growing demand for peptide-based drugs, which offer targeted and effective treatments with fewer side effects compared to traditional small molecules. The peptide synthesis market is segmented by end users into pharmaceutical and biotechnology companies, CDMOS & CROS, academic and research institutes, medical device companies, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment held the largest market share in 2023. The rise of peptide-based drugs and biologics has led to increased investments by pharmaceutical and biotech firms in peptide synthesis technologies, particularly in the production of therapeutic peptides for diseases such as cancer, diabetes, and autoimmune disorders. These factors are fueling the growth of the segment. The market is segmented by region into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America dominated the peptide synthesis market in 2023, and the Asia Pacific region is likely to grow at a significant CAGR during the forecast period. US-dominated North American peptide synthesis market owing to the presence of strong pharmaceutical and biotechnology companies in the country, advanced research infrastructure, and significant investments in drug discovery and development. The Asia Pacific region is anticipated to grow at a significant CAGR due to growing focus on personalized medicine and peptide-based therapeutics in the region fuels the demand for advanced peptide synthesis technologies. The market for peptide synthesis market is competitive, with key players strategizing to capture the majority market share. Prominent players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies Inc. (US), Kaneka Corporation (Japan), GenScript (China), and Bachem Holding AG (Switzerland), among others. The market players have adopted various organic and inorganic growth strategies, such as the development of advanced products, partnerships, agreements, expansions, and acquisitions to strengthen their position in the peptide synthesis market. Thermo Fisher Scientific Inc. is one of the dominant players in the peptide synthesis market. The company's leading position is attributable to its diversified product portfolio, strong geographic presence, and adoption of various growth strategies. The company offers a wide range of peptide synthesis products and services. The company has adopted different growth strategies, such as deals that include agreements, and acquisitions, to maintain its leading position in the peptide synthesis market. The company's strong customer support and extensive distribution network further solidify the company's leadership position in the market. Merck KGaA is a key player in the peptide synthesis market, leveraging its expertise in life sciences and advanced chemical technologies. The company's Novabiochem product line offers a broad range of high-quality reagents, resins, and building blocks essential for efficient and reliable peptide synthesis. Merck KGaA focuses on innovation supporting advanced techniques such as microwave-assisted synthesis, which significantly improves reaction efficiency and yield. The company's strategic partnerships and increased investments in biopharmaceutical R&D further enhance its competitive edge in the market. Merck's strong geographic presence and adoption of growth strategies further contribute to its dominance in the market. For more information, Inquire Now!
Globe and Mail
2 days ago
- Globe and Mail
DHL Express Canada to suspend operations with 2,100 workers involved in strike, lockout
DHL Express Canada DHL-NE plans to shut down operations across the country this week amid a strike and lockout involving 2,100 truck drivers and other workers, adding to turmoil in the parcel market. With the two sides at an impasse, the company said it will halt thousands of daily deliveries starting Friday – the same day that federal legislation banning replacement workers takes full effect. DHL will stop receiving inbound packages to Canada from abroad on Tuesday at 9 p.m., DHL said in an e-mail. Spokeswoman Pamela Duque Rai pointed to stalled negotiations with Unifor and the legislation known as Bill C-58, 'which prohibits the use of replacement workers during industrial action,' she noted. On June 8, the German-owned carrier said it was rolling out a 'contingency plan' that allowed it to keep serving its more than 50,000 customers, which range from retailer Lululemon to e-commerce giants Shein and Temu. Duque Rai had said in an e-mail at the time that DHL did not expect 'significant disruptions' to its service. Unifor, which represents DHL truck drivers, couriers and warehouse and call centre employees, had warned against any steps to supplant unionized workers with temporary ones, with president Lana Payne saying the move would impose a chill on contract talks. Last Friday, Unifor's bargaining committee said it had met with DHL Express Canada CEO Geoff Walsh, who stressed the possibility of a halt the following week. 'We will not be intimidated by the company's threats to disrupt service or shut down operations,' the committee said in a June 13 bulletin to members. The upcoming pause adds to the labour tumult in the parcel sector, as Canada Post remains at loggerheads with 55,000 workers amid strained negotiations and an overtime ban imposed by the union last month. Canada is not the only country struggling with falling mail volumes – a key factor in the impasse between the two sides – and DHL is among those feeling the pinch. In March it announced plans to cut 8,000 jobs in Germany this year, marking the largest set of layoffs in its home market in decades. Back in Canada, Duque Rai sought to frame the union's proposals as unreasonable. 'While we are committed to fair compensation for our employees, our position is that Unifor's demands – a 22 per cent salary increase for hourly employees, as well as a 42 per cent salary increase for owner-operators – do not reflect the current economic landscape and would jeopardize our operational viability,' she said. Payne said DHL has been seeking concessions since negotiations kicked off nearly a year ago. She highlighted a push by the company to change the pay model for owner-operators – roughly 500 independent contractors drive for DHL and also have union membership – in a way she claimed would reduce their compensation, not boost it. 'What we've seen over many months of bargaining are what I would say is an attempt to divide workers in classifications, pit one group against another, pit one region against another,' Payne said in a phone interview on June 8. A group of employers expressed concerns Tuesday about the effect of legislation passed under the previous Liberal government to ban replacement workers in federally regulated workplaces, pointing to DHL as the latest example of potential disruption. 'Canadians should prepare for more frequent and prolonged work stoppages that can impact supply chains, critical infrastructure and the broader economy,' said Daniel Safayeni, CEO of Federally Regulated Employers – Transportation and Communications, in a statement. The group called for a more 'balanced labour relations framework.' In contrast, labour groups have decried federal intervention in labour disputes over the past year, including strikes by railworkers, B.C. dockworkers and WestJet mechanics. Unifor has said its bargaining priorities with DHL revolve around wages, working conditions and surveillance and automation in the workplace.
CTV News
2 days ago
- CTV News
DHL Express to suspend operations countrywide amid strike, lockout
An airplane stands in the hangar during the official launching ceremony of the Airbus A330-200 cargo airplane by the European Air Transport Leipzig GmbH (EAT) at the European DHL Express air freight hub in Schkeuditz near Leipzig, Germany, Friday, Oct. 12, 2018. (AP Photo/Jens Meyer)
